CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.

Fabienne Caby, Marguerite Guiguet, Laurence Weiss, Alan Winston, Jose M Miro, Deborah Konopnicki, Vincent Le Moing, Fabrice Bonnet, Peter Reiss, Cristina Mussini, Isabelle Poizot-Martin, Ninon Taylor (Co-author), Athanasios Skoutelis, Laurence Meyer, Cécile Goujard, Barbara Bartmeyer, Christoph Boesecke, Andrea Antinori, Eugenia Quiros-Roldan, Linda WittkopCasper Frederiksen, Antonella Castagna, Maria Christine Thurnheer, Veronica Svedhem, Sophie Jose, Dominique Costagliola, Murielle Mary-Krause, Sophie Grabar

Research output: Contribution to journalOriginal Articlepeer-review

22 Citations (Web of Science)
Original languageEnglish
Pages (from-to)50-59
JournalCLINICAL INFECTIOUS DISEASES
Volume73
Issue number1
DOIs
Publication statusPublished - 2021

Keywords

  • COMBINATION ANTIRETROVIRAL THERAPY
  • IMMUNE ACTIVATION
  • AIDS
  • INDIVIDUALS
  • MARKERS
  • EVENTS
  • CANCER

Cite this